
Evetra MF 500mg/250mg Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Tranexamic Acid (500mg) + Mefenamic Acid (250mg)
Overview Evetra MF 500mg/250mg Tablet
Combifem 500 mg/250 mg tablets are prescribed for managing heavy menstrual bleeding and associated discomfort. This medication works by inhibiting clot breakdown, thus reducing excessive menstrual flow. It also suppresses the production of pain-inducing and inflammatory substances. The tablets may be ingested with or without food, at any time of day; however, consistent daily timing is recommended, ideally commencing on the first day of menstruation for optimal efficacy. Continue the prescribed course as directed by your physician. If a dose is missed, take it as soon as possible. Complete the entire treatment regimen, even if symptoms improve. Consult your doctor if no improvement in menstrual bleeding is observed after three consecutive cycles. Common side effects include nausea, abdominal pain, headache, nasal congestion, sinusitis, skin rash, fatigue, and musculoskeletal pain. Diarrhea is also possible; increased fluid intake is advisable to prevent dehydration. If menstrual bleeding remains unchanged after three cycles, seek medical advice. Prior to initiating treatment, inform your physician of any kidney issues, vaginal bleeding disorders, pregnancy, breastfeeding, or other medications being taken. Regular eye examinations may be necessary while on this medication. Alcohol consumption should be avoided during treatment.
Primary Ingredients of Evetra MF 500mg/250mg Tablet
There is no text provided to rephrase.
Uses of Evetra MF 500mg/250mg Tablet
Managing excessive menstrual flow and menstrual discomfort.
Major Benefits of Evetra MF 500mg/250mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Evetra MF 500 mg/250 mg Tablet should be administered with a meal.
Common Side effects of Evetra MF 500mg/250mg Tablet:
- Nausea
- Vomiting
- Heartburn
- Indigestion
- Diarrhea
- Loss of appetite
- Nasal congestion (stuffy nose)
- Headache
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
- Stomach pain
- Sinus pain
- Sinus inflammation
How to use Evetra MF 500mg/250mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Evetra MF 500 mg/250 mg Tablet should be administered with food.
How Evetra MF 500mg/250mg Tablet works:
Combining Tranexamic Acid (500mg) and Mefenamic Acid (250mg), Evetra MF tablets offer dual action. Tranexamic Acid, an antifibrinolytic agent, reduces menstrual bleeding by stabilizing blood clots. Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), alleviates pain and inflammation by inhibiting prostaglandin synthesis, the chemical mediators responsible for these symptoms.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Evetra MF 500 mg/250 mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Evetra MF 500 mg/250 mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before using this medication.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Evetra MF 500 mg/250 mg tablets appear compatible. Available human data indicates minimal infant risk associated with this medication.
DrivingUNSAFE
Taking Evetra MF 500 mg/250 mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Evetra MF 500 mg/250 mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Evetra MF 500 mg/250 mg tablets are contraindicated in individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
Use of Evetra MF 500 mg/250 mg tablets in patients with liver conditions appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Evetra MF 500mg/250mg Tablet :
Should you forget to take your Evetra MF 500 mg/250 mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Evetra MF 500mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Therapy | KINSHIP |
